Transforming growth factor β1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells

Atherosclerosis

Volumn 136, Issue 2, 1998, Pages 377-382

  Di Febbo, Concetta ^a   Baccante, Giovanna ^a   Reale, Marcella ^a   Castellani, Maria Luisa ^a   Angelini, Antonio ^a   Cuccurullo, Franco ^a   Porreca, Ettore ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Atherogenesis; IL 1 receptor antagonist; Transforming growth factor ; Vascular smooth muscle cells

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIOSCLEROSIS; CELLS, CULTURED; GENE EXPRESSION; MUSCLE, SMOOTH, VASCULAR; RATS; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032006178     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00240-2     Document Type: Article

References (31)

1. Sporn M.B., Roberts A.B. Transforming growth factor-β: recent progress and new challenges. J Cell Biol. 119:1992;1017-1021.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for 1990s. Nature. 362:1993;801-809.
3. Owens G.K., Geisterfer A.A.T., Yang Y.W.H., Komoriya A. Transforming growth factor-β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol. 107:1988;771-780.
4. McCaffrey T.A., Consigli S., Du B., Falcone D., Sanborn T.A., Spokojny A.M., Bush H.L. Jr. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions. J Clin Invest. 96:1995;2667-2675.
5. 1 during repair of arterial injury. J Clin Invest. 88:1991;904-910.
6. 1 is increased in human vascular restenosis lesions. J Clin Invest. 90:1992;1582-1592.
7. Battegay E.J., Raines E.W., Seifert R.A., Bowen-Pope D.F., Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 63:1990;515-524.
8. 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA. 90:1993;10759-10763.
9. Libby P., Ordovas J.M., Birinyi L.K., Auger K.R., Dinarello C.A. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest. 78:1986;1432-1438.
10. Loppnow H., Libby P. Functional significance of human vascular smooth muscle cell-derived interleukin-1 in paracrine and autocrine regulation pathways. Exp Cell Res. 198:1992;283-290.
11. Beasley D., McGuiggin M.E., Dinarello C.A. Human vascular smooth muscle cells produce an intracellular form of interleukin-1 receptor antagonist. Am J Physiol. 269:1995;C961-968.
12. Wahl S.M., McCartney-Francis N., Mergenhagen S.E. Inflammatory and immunomodulatory roles of TGF-β Immunol Today. 10:1989;258-261.
13. Turner M., Chantry D., Katsikis P., Berger A., Brennan M.F., Feldmann M. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β Eur J Immunol. 21:1991;1635-1639.
14. Wahl S.M., Costa G.L., Corcoran M., Wahl L.M., Berger A.E. Transforming growth factor-β mediates IL-1-dependent induction of IL-1 receptor antagonist. J Immunol. 150:1993;3553-3560.
15. Porreca E., Di Febbo C., Pandolfi A., D'Orazio A., Martelli N., Mezzetti A., Cuccurullo F., Poggi A. Differences in the glutathione system of cultured aortic smooth muscle cells from young and aged rats: effect of DL-buthionine SR-sulphoximine. Atherosclerosis. 100:1993;141-148.
16. Chomzynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
17. Bossù P., Visconti U., Ruggiero P., Macchia G., Muda M., Bertini R., Bizzarri C., Colagrande A., Sabbatini V., Maurizi G., Del Grosso E., Tagliabue A., Boraschi D. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. Am J Pathol. 147:1995;1852-1861.
18. Jenkins J.K., Arend W.P. Interleukin 1 Receptor Antagonist production in human monocytes is induced by IL-1α, IL-3, IL-4 and GM-CSF. Cytokine. 5:1993;407-415.
19. Kutsch C.L., Norris D.A., Arend W.P. Tumor necrosis factor-α induces interleukin-1α and interleukin-1 receptor antagonist production by cultured human keratinocytes. J Invest Dermatol. 101:1993;79-85.
20. Poutsiaka D.D., Clark B.D., Vannier E., Dinarello C.A. Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated. Blood. 78:1991;1275-1281.
21. Bigler C.F., Norris D.A., Weston W.L., Arend W.P. Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol. 98:1992;38-44.
22. Haskill S., Martin G., Van Le L., Morris J., Peace A., Bigler G.F., Jalle G.J., Hammerberg C., Sporn S.A., Fong S., Arend W.P., Ralph P. cDNA cloning of an intracellular form of the human interleukin-1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA. 88:1991;3681-3685.
23. Bertini R., Sironi M., Martin-Padura I., Colotta S., Rambaldi S., Bernasconi S., Ghezzi P., Haskill S.J., Liu D., Mantovani A. Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activation. Cytokine. 4:1992;44-47.
24. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood. 77:1991;1627-1652.
25. Dinarello C.A., Wolff S.M. The role of interleukin-1 in disease. N Engl J Med. 328:1993;106-113.
26. Wang A.M., Doyle M.V., Mark D.F. Quantitation of mRNA using the polymerase chain reaction. Proc Natl Acad Sci USA. 86:1989;9717-9721.
27. Tipping P.G., Hancock W.W. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaque. Am J Pathol. 142:1993;1721-1728.
28. Galea J., Armstrong J., Gadsdon P., Holden H., Francis S.E., Holt C.M. Interleukin-1β in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol. 16:1996;1000-1006.
29. Munro J.M., Cotran R.S. The pathogenesis of atherosclerosis and inflammation. Lab Invest. 58:1988;249-261.
30. Libby P., Hansson G.K. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 64:1991;5-15.
31. Porreca E., Di Febbo C., Barbacane R.C., Panara M.R., Cuccurullo F., Conti P. Effect of interleukin-1 receptor antagonist on vascular smooth muscle cell proliferation. Atherosclerosis. 99:1993;71-78.